pCMV-Neo-Bam Citations (22)

Originally described in: Suppression of human colorectal carcinoma cell growth by wild-type p53.
Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B Science. 1990 Aug 24. 249(4971):912-5. PubMed Journal

---

Articles Citing pCMV-Neo-Bam

Articles
Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. Liebl J, Weitensteiner SB, Vereb G, Takacs L, Furst R, Vollmar AM, Zahler S. J Biol Chem. 2010 Nov 12;285(46):35932-43. doi: 10.1074/jbc.M110.126177. Epub 2010 Sep 7. PubMed
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Ferreira DM, Afonso MB, Rodrigues PM, Simao AL, Pereira DM, Borralho PM, Rodrigues CM, Castro RE. Mol Cell Biol. 2014 Mar;34(6):1100-20. doi: 10.1128/MCB.00420-13. Epub 2014 Jan 13. PubMed
End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo. Berges R, Baeza-Kallee N, Tabouret E, Chinot O, Petit M, Kruczynski A, Figarella-Branger D, Honore S, Braguer D. Oncotarget. 2014 Dec 30;5(24):12769-87. PubMed
Development of a genetic sensor that eliminates p53 deficient cells. Mircetic J, Dietrich A, Paszkowski-Rogacz M, Krause M, Buchholz F. Nat Commun. 2017 Nov 13;8(1):1463. doi: 10.1038/s41467-017-01688-w. PubMed
Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro. Liu M, Wang Z, Liu Q, Zhu H, Xu N. Med Sci Monit. 2018 Oct 30;24:7750-7758. doi: 10.12659/MSM.911585. PubMed
Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells. Saini H, Hakeem I, Mukherjee S, Chowdhury S, Chowdhury R. J Oncol. 2019 Jan 6;2019:6164807. doi: 10.1155/2019/6164807. eCollection 2019. PubMed
Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression. Yi Y, Cheng JC, Klausen C, Leung PCK. Exp Cell Res. 2019 Jun 20. pii: S0014-4827(19)30311-8. doi: 10.1016/j.yexcr.2019.06.016. PubMed
p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition. Aggarwal M, Saxena R, Asif N, Sinclair E, Tan J, Cruz I, Berry D, Kallakury B, Pham Q, Wang TTY, Chung FL. J Exp Clin Cancer Res. 2019 Jul 15;38(1):307. doi: 10.1186/s13046-019-1267-z. PubMed
Interaction of promyelocytic leukemia/p53 affects signal transducer and activator of transcription-3 activity in response to oncostatin M. Lim J, Choi JH, Park EM, Choi YH. Korean J Physiol Pharmacol. 2020 May 1;24(3):203-212. doi: 10.4196/kjpp.2020.24.3.203. PubMed
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells. Saini H, Sharma H, Mukherjee S, Chowdhury S, Chowdhury R. Cancer Cell Int. 2021 Jan 14;21(1):52. doi: 10.1186/s12935-020-01720-y. PubMed
O-GlcNAcylated p53 in the liver modulates hepatic glucose production. Gonzalez-Rellan MJ, Fondevila MF, Fernandez U, Rodriguez A, Varela-Rey M, Veyrat-Durebex C, Seoane S, Bernardo G, Lopitz-Otsoa F, Fernandez-Ramos D, Bilbao J, Iglesias C, Novoa E, Ameneiro C, Senra A, Beiroa D, Cunarro J, Dp Chantada-Vazquez M, Garcia-Vence M, Bravo SB, Da Silva Lima N, Porteiro B, Carneiro C, Vidal A, Tovar S, Muller TD, Ferno J, Guallar D, Fidalgo M, Sabio G, Herzig S, Yang WH, Cho JW, Martinez-Chantar ML, Perez-Fernandez R, Lopez M, Dieguez C, Mato JM, Millet O, Coppari R, Woodhoo A, Fruhbeck G, Nogueiras R. Nat Commun. 2021 Aug 20;12(1):5068. doi: 10.1038/s41467-021-25390-0. PubMed
Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation. Hauffe L, Picard D, Musa J, Remke M, Grunewald TGP, Rotblat B, Reifenberger G, Leprivier G. Cell Death Discov. 2022 Feb 28;8(1):91. doi: 10.1038/s41420-022-00883-z. PubMed
p53 mutants G245S and R337H associated with the Li-Fraumeni syndrome regulate distinct metabolic pathways. Meneghetti BV, Wilson R, Dias CK, Cadore NA, Klamt F, Zaha A, Ferreira HB, Monteiro KM. Biochimie. 2022 Jul;198:141-154. doi: 10.1016/j.biochi.2022.03.003. Epub 2022 Apr 1. PubMed
Antioncogenic and promyogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma. Di Rocco A, Camero S, Benedetti A, Lozanoska-Ochser B, Megiorni F, Marchese C, Stramucci L, Ciccarelli C, Bouche M, Bossi G, Marampon F, Zani BM. Oncol Rep. 2022 Sep;48(3). pii: 151. doi: 10.3892/or.2022.8363. Epub 2022 Jul 8. PubMed
Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. Iwahashi N, Ikezaki M, Komohara Y, Fujiwara Y, Noguchi T, Nishioka K, Sakai K, Nishio K, Ueda M, Ihara Y, Uchimura K, Ino K, Nishitsuji K. PNAS Nexus. 2022 Jul 25;1(3):pgac128. doi: 10.1093/pnasnexus/pgac128. eCollection 2022 Jul. PubMed
Tumor-suppressive role of the musculoaponeurotic fibrosarcoma gene in colorectal cancer. Itakura H, Hata T, Okuzaki D, Takeda K, Iso K, Qian Y, Morimoto Y, Adachi T, Hirose H, Yokoyama Y, Ogino T, Miyoshi N, Takahashi H, Uemura M, Mizushima T, Hinoi T, Mori M, Doki Y, Eguchi H, Yamamoto H. iScience. 2023 Mar 23;26(4):106478. doi: 10.1016/j.isci.2023.106478. eCollection 2023 Apr 21. PubMed
The Capicua C1 Domain is Required for Full Activity of the CIC::DUX4 Fusion Oncoprotein. Luck C, Jacobs KA, Okimoto RA. bioRxiv [Preprint]. 2024 Jun 9:2024.06.06.597815. doi: 10.1101/2024.06.06.597815. PubMed
The Capicua C1 Domain Is Required for Full Activity of the CIC::DUX4 Fusion Oncoprotein. Luck C, Jacobs KA, Okimoto RA. Cancer Res Commun. 2024 Dec 1;4(12):3099-3113. doi: 10.1158/2767-9764.CRC-24-0348. PubMed
The deubiquitinase inhibitor WP1130 drives nuclear aggregation and reactivation of mutant p53 for selective cancer cell targeting. Oak S, Karajgikar O, Gadewal N, Sulkshane P, Verma T, Gupta S, Teni T. FEBS J. 2025 Jun;292(11):2823-2842. doi: 10.1111/febs.70036. Epub 2025 Mar 11. PubMed
PTEN and p53 Combined Gene Therapy Promote Apoptosis and Chemosensitivity to Oxaliplatin in Colorectal Cancer: An In Vitro Study. Nakhaee N, Zeinali S, Kabiri M, Teimoori-Toolabi L. Adv Pharm Bull. 2025 Feb 9;15(1):154-161. doi: 10.34172/apb.43371. eCollection 2025 Apr. PubMed
Targeted citrullination enables p53 binding to non-canonical sites. Indeglia A, Valdespino A, Pantella G, Offley S, Hill C, Foster M, Casey K, Tang HY, Faustino AM, Gardini A, Murphy ME. Mol Cell. 2025 Oct 2;85(19):3588-3604.e11. doi: 10.1016/j.molcel.2025.09.004. PubMed
A smart gene circuit for precise regulation of tumor cell behavior. Fu H, Zhou Z, Fang L, Wang Q, Tang X, Su W, Chen X, Tang Y, Zhou Q. Synth Syst Biotechnol. 2025 Sep 22;11:237-246. doi: 10.1016/j.synbio.2025.09.016. eCollection 2026 Mar. PubMed

If you have published an article using this material, please email us at to have your article added to this page.